I guess I'd say a couple of things in response to that.
First, I would echo Kevin Stringer's comment to the effect that, just to be clear, there's nothing in the supplementary (C)s that addresses those issues materially, if there's any question about how that links.
With respect to the paper, we're aware of it. We have people who are looking at its conclusions. The debate around many of the topics that it touches on is a very robust one, as you know.
Insofar as lab capacity is concerned, on some of the issues that are touched upon, not only in the paper but in the regulatory domain that gets into that same field, lab capacity in that particular area for the most part is not a problem for us. We have lab capacity shortages in certain areas as compared to the demand upon them, because demand has continued to increase, but in this area our ability to meet the laboratory testing requirements and activities we think is actually quite sufficient.
Should the demand change, then we might have to think about different approaches to it, but for the most part, our lab facilities across the country—we have four that we use mostly for this sort of work—are extremely busy. They're working at full capacity, but their ability to touch on these sorts of things is quite high.
We also work in collaboration with people in the university community and in other agencies when we get into some of the other issues that are about more food safety and other things, so they're not only in DFO labs. We do have access to that set of expertise as well.